A PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CONTINUED ENZALUTAMIDE TREATMENT BEYOND PROGRESSION IN PATIENTS WITH CHEMOTHERAPY-NAÏVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
A PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CONTINUED ENZALUTAMIDE TREATMENT BEYOND PROGRESSION IN PATIENTS WITH CHEMOTHERAPY-NAÏVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
The purpose of this study is to determine if continued treatment with Enzalutamide is effective in patients with metastatic prostate cancer.
Inclusion Criteria:
Exclusion Criteria:
Port Macquarie, New South Wales 2444, Australia
Arhus N, 8200, Denmark
Meldola, FC 47014, Italy
Cremona, 26100, Italy
Orbassano to, 10043, Italy
Orbassano to, 10043, Italy
Orbassano to, 10043, Italy
Roma, 00152, Italy